A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth.

Rob C Roovers; Maria J W D Vosjan; Toon Laeremans; Rachid el Khoulati; Renée C G de Bruin; Kathryn M Ferguson; Arie J Verkleij; Guus A M S van Dongen; Paul M P van Bergen en Henegouwen

doi:10.1002/ijc.26145

A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth.

Identifier:nobleid.org/w1/20260515/EB6EB569

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EB6EB569.svg?ark=w1%2F20260515%2FEB6EB569)](https://nobleid.org/work/w1/20260515/EB6EB569)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Guus A M S van Dongen

Paul M P van Bergen en Henegouwen

Claim authorship of this work

A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth.

Identifier:nobleid.org/w1/20260515/EB6EB569

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EB6EB569.svg?ark=w1%2F20260515%2FEB6EB569)](https://nobleid.org/work/w1/20260515/EB6EB569)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Guus A M S van Dongen

Paul M P van Bergen en Henegouwen

Claim authorship of this work